SCHEMBL10104461

SCHEMBL10104461

Cc1cc(CN2CC(O)C2)c(Cl)c(C(F)(F)F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 7/20 0.37
CD274 Q9NZQ7 4/20 0.36
PDCD1LG2 Q9BQ51 3/20 0.36
RORC P51449 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PDCD1 Q15116 1/20 0.34
SYK P43405 2/20 0.34
DDR1 Q08345 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
SCN9A Q15858 1/20 0.34
HSPA5 P11021 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104455 0.86 SCN9A (0.40) S1PR1NPSR1KDM4EMEN1KMT2A
SCHEMBL10104431 0.81 KDM4E (0.43) NPSR1KDM4EMEN1KMT2AATM
SCHEMBL10104470 0.81 KDM4E (0.46) NPSR1KDM4EMEN1KMT2AATM
SCHEMBL10104460 0.80 KDM4E (0.43) NPSR1KDM4EMEN1KMT2AATM
SCHEMBL10104463 0.79 NR1H2 (0.53) NPSR1KDM4EMEN1KMT2AATM
SCHEMBL10104450 0.78 CYP2A13 (0.44) RORCNPSR1MEN1KMT2AATM
SCHEMBL10104436 0.77 RORC (0.46) RORCNPSR1KDM4EMEN1KMT2A
SCHEMBL10663593 0.75 HSPA5 (0.46) ALDH1A1HSPA5
SCHEMBL10104527 0.74 HSPA5 (0.42) S1PR1RORCALDH1A1HSPA5
SCHEMBL10767971 0.71 HSPA5 (0.38) HSPA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 S1PR1 1237/4885CD274 463/4885PDCD1LG2 1293/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 S1PR1 452/4885CD274 168/4885PDCD1LG2 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.